Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Lewitzka

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Bipolar Disorders|July 18, 2015
The suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewU Lewitzka, E Severus, R Bauer, et al.
Acta Psychiatrica Scandinavica|February 27, 2004
Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjectsT Bschor, M Ising, M Bauer, et al.
Der Nervenarzt|January 15, 2020
[German S3 guidelines on bipolar disorders-first update 2019 : What is new in pharmacotherapy?]T Bschor, C Baethge, H Grunze, et al.
Der Nervenarzt|September 6, 2015
[Is there an increased risk for renal tumors during long-term treatment with lithium?]J Conell, U Lewitzka, P Ritter, et al.
Pharmacopsychiatry|May 6, 2011
Comparison of pre-episode and pre-remission states using mood ratings from patients with bipolar disorderM Bauer, T Glenn, M Alda, et al.
Pharmacopsychiatry|May 23, 2012
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidoneF Seemüller, U Lewitzka, M Bauer, et al.
Pharmacopsychiatry|July 9, 2014
Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic functionI Uhl, J A Bez, T Stamm, et al.
Pharmacopsychiatry|June 26, 2013
Regularity in daily mood stabilizer dosage taken by patients with bipolar disorderM Bauer, T Glenn, M Alda, et al.
Acta Psychiatrica Scandinavica|September 24, 2008
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trialE Lauterbach, W Felber, B Müller-Oerlinghausen, et al.
Acta Psychiatrica Scandinavica|November 22, 2007
Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?U Lewitzka, B Müller-Oerlinghausen, W Felber, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Bipolar Disorders|July 18, 2015
The suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewU Lewitzka, E Severus, R Bauer, et al.
Acta Psychiatrica Scandinavica|February 27, 2004
Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjectsT Bschor, M Ising, M Bauer, et al.
Der Nervenarzt|January 15, 2020
[German S3 guidelines on bipolar disorders-first update 2019 : What is new in pharmacotherapy?]T Bschor, C Baethge, H Grunze, et al.
Der Nervenarzt|September 6, 2015
[Is there an increased risk for renal tumors during long-term treatment with lithium?]J Conell, U Lewitzka, P Ritter, et al.
Pharmacopsychiatry|May 6, 2011
Comparison of pre-episode and pre-remission states using mood ratings from patients with bipolar disorderM Bauer, T Glenn, M Alda, et al.
Pharmacopsychiatry|May 23, 2012
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidoneF Seemüller, U Lewitzka, M Bauer, et al.
Pharmacopsychiatry|July 9, 2014
Influence of levothyroxine in augmentation therapy for bipolar depression on central serotonergic functionI Uhl, J A Bez, T Stamm, et al.
Pharmacopsychiatry|June 26, 2013
Regularity in daily mood stabilizer dosage taken by patients with bipolar disorderM Bauer, T Glenn, M Alda, et al.
Acta Psychiatrica Scandinavica|September 24, 2008
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trialE Lauterbach, W Felber, B Müller-Oerlinghausen, et al.
Acta Psychiatrica Scandinavica|November 22, 2007
Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?U Lewitzka, B Müller-Oerlinghausen, W Felber, et al.
Pageof 3